KCM

Kynam Capital Management Portfolio holdings

AUM $929M
This Quarter Return
-21.29%
1 Year Return
-7.66%
3 Year Return
+163.82%
5 Year Return
–
10 Year Return
–
AUM
$1.17B
AUM Growth
+$1.17B
Cap. Flow
-$26.5M
Cap. Flow %
-2.27%
Top 10 Hldgs %
74.05%
Holding
36
New
5
Increased
14
Reduced
4
Closed
3

Top Buys

1
PCVX icon
Vaxcyte
PCVX
$32.6M
2
CLDX icon
Celldex Therapeutics
CLDX
$26.1M
3
VERA icon
Vera Therapeutics
VERA
$22.6M
4
LEGN icon
Legend Biotech
LEGN
$20.7M
5
VRDN icon
Viridian Therapeutics
VRDN
$18.5M

Top Sells

1
NTRA icon
Natera
NTRA
$121M
2
DVAX icon
Dynavax Technologies
DVAX
$51.1M
3
LQDA icon
Liquidia Corp
LQDA
$24.1M
4
TSVT
2seventy bio
TSVT
$17.5M
5
PTGX icon
Protagonist Therapeutics
PTGX
$15.1M

Sector Composition

1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
STRO icon
26
Sutro Biopharma
STRO
$72.7M
$3.54M 0.3%
5,441,447
+1,800,000
+49% +$1.17M
DSGN icon
27
Design Therapeutics
DSGN
$315M
$3.49M 0.29%
+904,017
New +$3.49M
CRBU icon
28
Caribou Biosciences
CRBU
$174M
$2.99M 0.25%
3,269,147
+863,000
+36% +$788K
PRQR icon
29
ProQR Therapeutics
PRQR
$237M
$2.33M 0.2%
1,750,000
– –
CLYM
30
Climb Bio, Inc. Common Stock
CLYM
$151M
$1.28M 0.11%
1,047,000
+500,000
+91% +$610K
URGN icon
31
UroGen Pharma
URGN
$900M
$277K 0.02%
+25,000
New +$277K
PTGX icon
32
Protagonist Therapeutics
PTGX
$3.67B
– –
-390,792
Closed -$15.1M
SLNO icon
33
Soleno Therapeutics
SLNO
$3.6B
– –
0
– –
SLRN
34
DELISTED
ACELYRIN
SLRN
– –
-847,366
Closed -$2.66M
SPY icon
35
SPDR S&P 500 ETF Trust
SPY
$658B
– –
0
– –
TSVT
36
DELISTED
2seventy bio
TSVT
– –
-5,953,825
Closed -$17.5M
1
2